CalciMedica (CALC) Institutional Ownership $2.94 -0.50 (-14.53%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$2.94 +0.00 (+0.17%) As of 08/1/2025 06:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for CalciMedica (NASDAQ:CALC)Number ofInstitutional Buyers(last 12 months)15TotalInstitutional Inflows(last 12 months)$5.21MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$222.67K Get CALC Insider Trade Alerts Want to know when executives and insiders are buying or selling CalciMedica stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CALC Institutional Buying and Selling by Quarter CalciMedica Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/1/2025Envestnet Asset Management Inc.93,433$149K0.0%+58.2%0.669% 7/31/2025 180 Wealth Advisors LLC50,450$81K0.0%+207.6%0.361% 5/15/2025First Manhattan CO. LLC.13,226$25K0.0%N/A0.095% 5/14/2025Stonepine Capital Management LLC367,371$702K0.7%-21.6%2.629% 5/13/2025Wealthedge Investment Advisors LLC108,291$207K0.1%+289.3%0.775% 4/22/2025 Cambridge Investment Research Advisors Inc.23,539$45K0.0%N/A0.175% 4/9/2025 180 Wealth Advisors LLC16,400$31K0.0%N/A0.122% 3/12/2025Wealthedge Investment Advisors LLC27,819$98K0.0%N/A0.206% 2/17/2025Stonepine Capital Management LLC468,793$1.66M1.3%N/A3.478% 2/17/2025Millennium Management LLC72,057$255K0.0%+30.5%0.535% Get the Latest News and Ratings for CALC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CalciMedica and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025Deerfield Management Company L.P. Series C1,300,000$4.60M0.1%+30.0%9.644% 2/17/2025Cetera Investment Advisers16,873$60K0.0%+37.1%0.125% 2/17/2025Alyeska Investment Group L.P.372,256$1.32M0.0%N/A2.762% 2/13/2025Renaissance Technologies LLC43,200$153K0.0%N/A0.320% 2/12/2025Geode Capital Management LLC90,866$322K0.0%+36.5%0.674% 2/10/2025Corient Private Wealth LLC38,000$135K0.0%N/A0.282% 2/6/2025Atria Investments Inc34,012$120K0.0%+28.3%0.252% 11/25/2024PVG Asset Management Corp15,115$67K0.3%N/A0.112% 11/16/2024Geode Capital Management LLC66,553$295K0.0%+51.2%0.619% 11/5/2024BML Capital Management LLC153,887$682K0.4%-4.1%1.432% 11/1/2024Atria Investments Inc26,503$117K0.0%+136.5%0.247% 4/23/2024BML Capital Management LLC160,424$667K0.4%+10.3%1.494% 2/2/2024 Meritage Portfolio Management46,000$132K0.0%+360.0%0.810% 1/30/2024BML Capital Management LLC145,424$416K0.3%+63.8%2.560% 12/7/2023Hudson Bay Capital Management LP166,857$432K0.0%N/A2.938% 7/31/2023 Meritage Portfolio Management10,000$40K0.0%N/A0.177% 7/24/2023BML Capital Management LLC88,781$356K0.3%N/A1.568% (Data available from 1/1/2016 forward) CALC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CALC shares? During the previous two years, 18 institutional investors and hedge funds held shares of CalciMedica. The most heavily invested institutionals were Deerfield Management Company L.P. Series C ($4.60M), Alyeska Investment Group L.P. ($1.32M), Stonepine Capital Management LLC ($702K), BML Capital Management LLC ($682K), Hudson Bay Capital Management LP ($432K), Geode Capital Management LLC ($322K), and Millennium Management LLC ($255K).Learn more on CalciMedica's institutional investors. Which institutional investors have been buying CalciMedica's stock? Of the 18 institutional investors that purchased CalciMedica's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Stonepine Capital Management LLC ($468.79K), Alyeska Investment Group L.P. ($372.26K), Deerfield Management Company L.P. Series C ($300K), Hudson Bay Capital Management LP ($166.86K), Wealthedge Investment Advisors LLC ($108.29K), BML Capital Management LLC ($71.64K), and 180 Wealth Advisors LLC ($50.45K). How much institutional buying is happening at CalciMedica? Institutional investors have bought a total of 1,558,289 shares in the last 24 months. This purchase volume represents approximately $5.21M in transactions. Which of CalciMedica's major shareholders have been selling company stock? The following institutional investors have sold CalciMedica stock in the last 24 months: Stonepine Capital Management LLC ($101.42K), and BML Capital Management LLC ($6.54K). How much institutional selling is happening at CalciMedica? Institutional investors have sold a total of 107,959 shares in the last 24 months. This volume of shares sold represents approximately $222.67K in transactions. Related Companies CARGO Therapeutics Major Shareholders DiaMedica Therapeutics Major Shareholders 4D Molecular Therapeutics Major Shareholders Galectin Therapeutics Major Shareholders Eupraxia Pharmaceuticals Major Shareholders GENFIT Major Shareholders Innate Pharma Major Shareholders Lyell Immunopharma Major Shareholders Ventyx Biosciences Major Shareholders Semper Paratus Acquisition Major Shareholders This page (NASDAQ:CALC) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalciMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
